-+ 0.00%
-+ 0.00%
-+ 0.00%

Cogent Biosciences presents new 48-week SUMMIT trial data for bezuclastinib in NonAdvSM at AAAAI 2026

Reuters·02/28/2026 15:01:18

Please log in to view news